Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Transplantation

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 96 articles:
HTML format
Text format



Single Articles


    August 2018
  1. GORGIS NM, Kennedy C, Lam F, Thompson K, et al
    Clinical Consequences of Cardiomyopathy in Children with Biliary Atresia Requiring Liver Transplantation.
    Hepatology. 2018 Aug 3. doi: 10.1002/hep.30204.
    PubMed     Text format     Abstract available


  2. FORDE KA, Fallon MB, Krowka MJ, Sprys M, et al
    Pulse Oximetry is Insensitive for Detection of Hepatopulmonary Syndrome in Patients evaluated for Liver Transplantation.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30139.
    PubMed     Text format     Abstract available


  3. SQUIRES JE, Rudnick DA, Hardison RM, Horslen S, et al
    Liver Transplant Listing in Pediatric Acute Liver Failure (PALF): Practices and Participant Characteristics.
    Hepatology. 2018 Aug 2. doi: 10.1002/hep.30116.
    PubMed     Text format     Abstract available


    April 2018
  4. OLORUNTOBA OO, Moylan CA
    "Too Female" for liver transplantation.
    Hepatology. 2018 Apr 20. doi: 10.1002/hep.30053.
    PubMed     Text format    


  5. CHOLANKERIL G, Gadiparthi C, Kim D, Ahmed A, et al
    Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30043.
    PubMed     Text format    


  6. KWONG AJ, Kim WR, Flemming JA
    De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30045.
    PubMed     Text format     Abstract available


  7. CHHATWAL J, Bethea ED, Samur S, Chung RT, et al
    Reply to Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients.
    Hepatology. 2018 Apr 19. doi: 10.1002/hep.30042.
    PubMed     Text format    


  8. HOUSSEL-DEBRY P, Coilly A, Fougerou-Leurent C, Jezequel C, et al
    12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation.
    Hepatology. 2018 Apr 10. doi: 10.1002/hep.29918.
    PubMed     Text format     Abstract available


    February 2018
  9. HUANG AC, Mehta N, Dodge JL, Yao FY, et al
    Direct-acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence after Local-Regional Therapy or Liver Transplant Waitlist Dropout.
    Hepatology. 2018 Feb 24. doi: 10.1002/hep.29855.
    PubMed     Text format     Abstract available


  10. ZAMORA-VALDES D, Watt KD, Kellogg TA, Poterucha JJ, et al
    Long-term outcomes of patients undergoing simultaneous Liver Transplantation and Sleeve Gastrectomy.
    Hepatology. 2018 Feb 19. doi: 10.1002/hep.29848.
    PubMed     Text format     Abstract available


  11. MAZZAFERRO V, Droz Dit Busset M, Bhoori S
    Alpha-Fetoprotein (AFP) in liver transplantation for HCC: The lower, the better.
    Hepatology. 2018 Feb 9. doi: 10.1002/hep.29835.
    PubMed     Text format    


    January 2018
  12. MARTINI S, Caccamo L, Rizzetto M
    Are immunoglobulins against the HBsAg still needed in liver transplantation for hepatitis D?
    Hepatology. 2018 Jan 21. doi: 10.1002/hep.29796.
    PubMed     Text format    


  13. KAGEYAMA S, Nakamura K, Fujii T, Ke B, et al
    Recombinant Relaxin Protects Liver Transplants from Ischemia Damage via Hepatocyte Glucocorticoid Receptor: From Bench-to-Bedside.
    Hepatology. 2018 Jan 19. doi: 10.1002/hep.29787.
    PubMed     Text format     Abstract available


  14. CHALASANI N, Younossi Z, Lavine JE, Charlton M, et al
    The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
    Hepatology. 2018;67:328-357.
    PubMed     Text format    


    December 2017
  15. WINTER A, Daures JP, Landais P
    Intention-to-treat survival benefit in liver transplantation: comments on Lai et al.
    Hepatology. 2017 Dec 22. doi: 10.1002/hep.29755.
    PubMed     Text format    


  16. BARI K, Luckett K, Kaiser T, Diwan T, et al
    Hepatitis C Transmission from Seropositive, Non-Viremic Donors to Non-Hepatitis C Liver Transplant Recipients.
    Hepatology. 2017 Dec 2. doi: 10.1002/hep.29704.
    PubMed     Text format     Abstract available


    November 2017
  17. JARAMILLO-CALLE DA, Castano Quintero O, Marin JI, Cock-Rada AM, et al
    Is liver transplantation for intractable attacks of porphyria a viable treatment in a developing country?
    Hepatology. 2017 Nov 15. doi: 10.1002/hep.29650.
    PubMed     Text format    


    October 2017
  18. RAMMOHAN A, Reddy MS, Farouk M, Vargese J, et al
    Pembrolizumab for Metastatic Hepatocellular Carcinoma Following Live Donor Liver Transplantation: The Silver Bullet?
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29575.
    PubMed     Text format     Abstract available


  19. GONZALEZ SA, Trotter JF
    The Rise of the Opioid Epidemic and Hepatitis C Positive Organs: A New Era in Liver Transplantation.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29572.
    PubMed     Text format     Abstract available


  20. MONTANO-LOZA AJ, Mazurak VC, Ebadi M, Meza-Junco J, et al
    Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.
    Hepatology. 2017 Oct 10. doi: 10.1002/hep.29578.
    PubMed     Text format     Abstract available


    September 2017
  21. LIU X, Elmofti Y, Kulaga C, Gisi B, et al
    Societal perspectives' analysis for evaluating direct-acting antivirals affordability while awaiting liver transplant.
    Hepatology. 2017 Sep 27. doi: 10.1002/hep.29558.
    PubMed     Text format    


  22. ONO Y, Perez-Gutierrez A, Nakao T, Dai H, et al
    Graft-infiltrating PD-L1hi cross-dressed dendritic cells regulate anti-donor T cell responses in mouse liver transplant tolerance.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29529.
    PubMed     Text format     Abstract available


  23. VIONNET J, Pascual M, Testoni B, Combet C, et al
    Late hepatitis B reactivation following DAA-based treatment of recurrent hepatitis C in an anti-HBc-positive liver transplant recipient.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29528.
    PubMed     Text format    


  24. VANWAGNER LB, Ning H, Whitsett M, Levitsky J, et al
    In Reply To: Xue et al. "Developing a Prediction Model for Cardiovascular Risk after Orthotopic Liver Transplantation".
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29525.
    PubMed     Text format    


  25. XUE FS, Liu YY, Yang GZ
    Developing a Prediction Model for Cardiovascular Risk after Orthotopic Liver Transplantation.
    Hepatology. 2017 Sep 16. doi: 10.1002/hep.29527.
    PubMed     Text format    


    August 2017
  26. KULIK L, Heimbach JK, Zaiem F, Almasri J, et al
    Therapies for Patients with Hepatocellular Carcinoma Awaiting for Liver Transplantation: a Systematic Review and Meta-analysis.
    Hepatology. 2017 Aug 31. doi: 10.1002/hep.29485.
    PubMed     Text format     Abstract available


  27. PARIKH ND, Marrero WJ, Wang J, Steuer J, et al
    Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States.
    Hepatology. 2017 Aug 17. doi: 10.1002/hep.29473.
    PubMed     Text format     Abstract available


  28. DE HAAS RJ, Lim C, Bhangui P, Salloum C, et al
    Curative Salvage Liver Transplantation in Cirrhotic patients with Hepatocellular Carcinoma: An intention-to-treat analysis.
    Hepatology. 2017 Aug 14. doi: 10.1002/hep.29468.
    PubMed     Text format     Abstract available


  29. LAI JC, Covinsky KE, Dodge JL, Boscardin WJ, et al
    Development of a novel frailty index to predict mortality in patients with end-stage liver disease.
    Hepatology. 2017;66:564-574.
    PubMed     Text format     Abstract available


  30. AZOULAY D, Lahat E, Salloum C, Compagnon P, et al
    Heterotopic liver retransplantation for impossible former graft explantation.
    Hepatology. 2017;66:655-657.
    PubMed     Text format    


    July 2017
  31. GU J, Jeong S, Xia Q
    Intrahepatic cholangiocarcinoma arising from HBV Infection may be a highly selected population for liver transplantation.
    Hepatology. 2017 Jul 31. doi: 10.1002/hep.29413.
    PubMed     Text format    


  32. LUCEY MR
    Redefining successful treatment of severe alcoholic hepatitis.
    Hepatology. 2017 Jul 24. doi: 10.1002/hep.29398.
    PubMed     Text format    


  33. VANWAGNER LB, Ning H, Whitsett M, Levitsky J, et al
    A Point-based Prediction Model for Cardiovascular Risk in Orthotopic Liver Transplantation: The CAR-OLT Score.
    Hepatology. 2017 Jul 13. doi: 10.1002/hep.29329.
    PubMed     Text format     Abstract available


  34. CARDOSO FS, Pereira R, Alexandrino G, Bagulho L, et al
    Futility of care in patients with acute-on-chronic liver failure.
    Hepatology. 2017;66:292-294.
    PubMed     Text format    


    June 2017
  35. LAI Q, Vitale A, Iesari S, Finkenstedt A, et al
    Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer.
    Hepatology. 2017 Jun 27. doi: 10.1002/hep.29342.
    PubMed     Text format     Abstract available


  36. KWONG AJ, Goel A, Mannalithara A, Kim WR, et al
    Improved Post-Transplant Mortality After Share 35 for Liver Transplantation.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29301.
    PubMed     Text format     Abstract available


    May 2017
  37. GANE E
    Is HBIG still needed after liver transplantation for CHB?
    Hepatology. 2017 May 26. doi: 10.1002/hep.29292.
    PubMed     Text format    


  38. HAYASHI PH, Rockey D, Fontana RJ, Tillmann HL, et al
    Death and Liver Transplantation within Two Years of Onset of Drug-Induced Liver Injury.
    Hepatology. 2017 May 23. doi: 10.1002/hep.29283.
    PubMed     Text format     Abstract available


  39. SAMOYLOVA ML, Nigrini MJ, Dodge JL, Roberts JP, et al
    Biases in the reporting of hcc tumor sizes on the liver transplant waiting list.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29269.
    PubMed     Text format     Abstract available


  40. SAXENA V, Khungar V, Verna EC, Levitsky J, et al
    Safety and Efficacy of Current DAA Regimens in Kidney and Liver Transplant Recipients with Hepatitis C: Results from the HCV-TARGET Study.
    Hepatology. 2017 May 15. doi: 10.1002/hep.29258.
    PubMed     Text format     Abstract available


    April 2017
  41. DENEAU MR, El-Matary W, Valentino PL, Abdou R, et al
    The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
    Hepatology. 2017 Apr 8. doi: 10.1002/hep.29204.
    PubMed     Text format     Abstract available


    March 2017
  42. FUNG J, Wong T, Chok K, Chan A, et al
    Long Term Outcomes of Entecavir Monotherapy for Chronic Hepatitis B after Liver Transplantation: Results up to 8 years.
    Hepatology. 2017 Mar 31. doi: 10.1002/hep.29191.
    PubMed     Text format     Abstract available


  43. AHMED A, Gonzalez SA, Cholankeril G, Perumpail RB, et al
    Treatment of Patients Waitlisted for Liver Transplant with an All-Oral DAAs is a Cost-Effective Treatment Strategy in the United States.
    Hepatology. 2017 Mar 3. doi: 10.1002/hep.29137.
    PubMed     Text format     Abstract available


  44. ALONSO EM, Horslen SP, Behrens EM, Doo E, et al
    Pediatric acute liver failure of undetermined cause: A research workshop.
    Hepatology. 2017;65:1026-1037.
    PubMed     Text format     Abstract available


    February 2017
  45. CADIER B, Bulsei J, Nahon P, Seror O, et al
    Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.28961.
    PubMed     Text format     Abstract available


  46. LEE MW, Raman SS, Asvadi NH, Siripongsakun S, et al
    Radiofrequency Ablation of Hepatocellular Carcinoma as Bridge Therapy to Liver Transplantation: A Ten Year Intention-to-treat Analysis.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29098.
    PubMed     Text format     Abstract available


    January 2017
  47. BOYD A, Miailhes P, Lacombe K, Zoulim F, et al
    Potential effect of lamivudine-induced S-gene mutations on liver-related pathogenesis in hepatitis D virus infection.
    Hepatology. 2017 Jan 19. doi: 10.1002/hep.29062.
    PubMed     Text format    


  48. VERNA EC
    The Dynamic Landscape of Liver Transplant in the Era of Effective HCV Therapy.
    Hepatology. 2017 Jan 17. doi: 10.1002/hep.29054.
    PubMed     Text format    


  49. SHAKED A, Chang BL, Barnes MR, Sayre P, et al
    An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.
    Hepatology. 2017;65:269-280.
    PubMed     Text format     Abstract available


  50. TROTTER JF
    An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.
    Hepatology. 2017;65:15-17.
    PubMed     Text format    


    December 2016
  51. CILLO U, Vitale A, Polacco M, Fasolo E, et al
    Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.28998.
    PubMed     Text format    


  52. SAVALE L, Sattler C, Coilly A, Conti F, et al
    Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28990.
    PubMed     Text format     Abstract available


  53. GUPTA R, Gupta J
    Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28994.
    PubMed     Text format    


  54. SAPISOCHIN G, Bruix J
    In response to: Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28993.
    PubMed     Text format    


  55. MARTINI S, Salizzoni M, David E, Tandoi F, et al
    Favorable short-term outcome of HCV-positive liver graft with bridging fibrosis: A plea for very early viral eradication.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28978.
    PubMed     Text format     Abstract available


    November 2016
  56. DE VRIES EM, de Krijger M, Farkkila M, Arola J, et al
    Validation of the Prognostic Value of Histologic Scoring Systems in Primary Sclerosing Cholangitis; An International Cohort Study.
    Hepatology. 2016 Nov 23. doi: 10.1002/hep.28963.
    PubMed     Text format     Abstract available


  57. CHHATWAL J, Samur S, Kues B, Ayer T, et al
    Optimal Timing of Hepatitis C Treatment for Patients on the Liver Transplant Waiting List.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28926.
    PubMed     Text format     Abstract available


  58. FLEMMING JA, Kim WR, Brosgart CL, Terrault NA, et al
    Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28923.
    PubMed     Text format     Abstract available


    October 2016
  59. KALAFATELI M, Wickham F, Burniston M, Cholongitas E, et al
    Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The rfh cirrhosis Gfr.
    Hepatology. 2016 Oct 25. doi: 10.1002/hep.28891.
    PubMed     Text format     Abstract available


  60. EMOND JC, Griesemer AD
    Tolerance in clinical liver transplantation: The long road ahead.
    Hepatology. 2016 Oct 7. doi: 10.1002/hep.28862.
    PubMed     Text format    


    September 2016
  61. MULLIGAN DC
    The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyond.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28841.
    PubMed     Text format    


    August 2016
  62. TAWAR RG, Heydmann L, Bach C, Schuttrumpf J, et al
    Broad neutralization of hepatitis C virus resistant variants by Civacir(R) hepatitis C immune globulin.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28767.
    PubMed     Text format     Abstract available


  63. SAPISOCHIN G, Facciuto M, Rubbia-Brandt L, Marti J, et al
    Liver transplantation for "very early" intrahepatic cholangiocarcinoma. international retrospective study supporting a prospective assessment.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28744.
    PubMed     Text format     Abstract available


    July 2016
  64. LANGBERG KM, Taddei TH
    Balancing quality with quantity: The role of palliative care in managing decompensated cirrhosis.
    Hepatology. 2016 Jul 7. doi: 10.1002/hep.28717.
    PubMed     Text format    


    June 2016
  65. FENG S, Demetris AJ, Spain KM, Kanaparthi S, et al
    Five year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R.
    Hepatology. 2016 Jun 15. doi: 10.1002/hep.28681.
    PubMed     Text format     Abstract available


    May 2016
  66. YANG CH, Gombar S, Twist CJ, Gratzinger D, et al
    Plasmacytic post-transplant lymphoproliferative disorder with hyperviscosity syndrome in a child after liver transplant.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28657.
    PubMed     Text format    


  67. SAPISOCHIN G, Goldaracena N, Laurence JM, Dib M, et al
    The extended toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28643.
    PubMed     Text format     Abstract available


    March 2016
  68. GUTIERREZ JA, Landaverde C, Wells JT, Poordad F, et al
    Lorcaserin Use in the Management of Morbid Obesity in a Pre-Liver Transplant Patient.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28556.
    PubMed     Text format    


  69. FRIEDRICH K, Smit M, Brune M, Giese T, et al
    CD14 is associated with biliary stricture formation.
    Hepatology. 2016 Mar 11. doi: 10.1002/hep.28543.
    PubMed     Text format     Abstract available


  70. BERZIGOTTI A, Saran U, Dufour JF
    Physical activity and liver diseases.
    Hepatology. 2016;63:1026-40.
    PubMed     Text format     Abstract available


    January 2016
  71. TODO S, Yamashita K, Goto R, Zaitsu M, et al
    A Pilot Study of Operational Tolerance with a Regulatory T Cell-Based Cell Therapy in Living Donor Liver Transplantation.
    Hepatology. 2016 Jan 16. doi: 10.1002/hep.28459.
    PubMed     Text format     Abstract available


  72. POORDAD F, Schiff ER, Vierling JM, Landis C, et al
    Daclatasvir With Sofosbuvir and Ribavirin for HCV Infection With Advanced Cirrhosis or Post-Liver Transplant Recurrence.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28446.
    PubMed     Text format     Abstract available


  73. LIM KC, Chow PK
    Reply.
    Hepatology. 2016;63:345.
    PubMed     Text format    


  74. DE MATTOS AZ, de Mattos AA
    Model for end-stage liver disease-based allocation system: On the right path, but not there yet.
    Hepatology. 2016;63:344.
    PubMed     Text format    


    December 2015
  75. MAZZAFERRO V
    Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28420.
    PubMed     Text format    


    November 2015
  76. FERRER-FABREGA J, Forner A, Liccioni A, Miquel R, et al
    Prospective validation of "ab initio" liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28339.
    PubMed     Text format     Abstract available


  77. YAO FY, Fidelman N
    Re-accessing the Boundaries of Liver Transplantation for Hepatocellular Carcinoma: Where Do We Stand with Tumor Down-staging?
    Hepatology. 2015 Nov 11. doi: 10.1002/hep.28139.
    PubMed     Text format     Abstract available


  78. CAVALLIN M, Piano S, Angeli P
    Outpatients use of terlipressin for hepatorenal syndrome: Not for all, with caution and a wise liver transplant allocation policy.
    Hepatology. 2015 Nov 2. doi: 10.1002/hep.28324.
    PubMed     Text format    


    October 2015
  79. LAI JC, Dodge JL, Sen S, Covinsky K, et al
    Functional Decline in Patients with Cirrhosis Awaiting Liver Transplantation: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28316.
    PubMed     Text format     Abstract available


  80. AGUERO F, Forner A, Manzardo C, Valdivieso A, et al
    HIV Infection Does Not Worsen Prognosis of Liver Transplantation for Hepatocellular Carcinoma.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28321.
    PubMed     Text format     Abstract available


  81. STINDT J, Kluge S, Droge C, Keitel V, et al
    Bile Salt Export Pump-reactive Antibodies Form a Polyclonal, Multi-inhibitory Response in Antibody-induced BSEP Deficiency.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28311.
    PubMed     Text format     Abstract available


  82. HALAZUN KJ, Patzer RE, Rana AA, Samstein B, et al
    Reply: To PMID 24954365.
    Hepatology. 2015;62:1328-9.
    PubMed     Text format    


  83. YANG T, Lau WY, Huang B, Schwartz M, et al
    Transplantation for hepatocellular carcinoma: more haste, less speed?
    Hepatology. 2015;62:1327-8.
    PubMed     Text format    


    September 2015
  84. PONSIOEN CY, Chapman RW, Chazouilleres O, Hirschfield GM, et al
    Surrogate endpoints for clinical trials in primary sclerosing cholangitis; review and results from an International PSC Study Group consensus process.
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28256.
    PubMed     Text format     Abstract available


    August 2015
  85. ANTOINE DJ, Sabbisetti VS, Francis B, Jorgensen AL, et al
    Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen-Induced Liver Injury.
    Hepatology. 2015;62:591-9.
    PubMed     Text format     Abstract available


    July 2015
  86. BHARADWAJ S, Rivas JM, Jevenn A, Hanouneh I, et al
    Immunonutrition in Patients undergoing Liver Transplantation- Too Premature to Draw Conclusions.
    Hepatology. 2015 Jul 23. doi: 10.1002/hep.28004.
    PubMed     Text format    


  87. BAJAJ JS
    Liver Capsule: Hepatic Encephalopathy.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27984.
    PubMed     Text format    


  88. KIRSTEIN MM, Metzler F, Geiger E, Heinrich E, et al
    Prediction of short- and long-term outcome in patients with autoimmune hepatitis.
    Hepatology. 2015 Jul 14. doi: 10.1002/hep.27983.
    PubMed     Text format     Abstract available


  89. GUSTOT T, Fernandez J, Garcia E, Morando F, et al
    Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.
    Hepatology. 2015;62:243-52.
    PubMed     Text format     Abstract available


    May 2015
  90. ZAMBAM DE MATTOS A, Alves de Mattos A
    Hepatocellular carcinoma - to resect or to transplant?
    Hepatology. 2015 May 29. doi: 10.1002/hep.27919.
    PubMed     Text format    


  91. MORITA M, Joyce D, Miller C, Fung JJ, et al
    Rejection triggers liver transplant tolerance: Involvements of mesenchyme-mediated Immune Control Mechanisms.
    Hepatology. 2015 May 22. doi: 10.1002/hep.27909.
    PubMed     Text format     Abstract available


    April 2015
  92. BANERJEE S, Wang DS, Kim HJ, Sirlin CB, et al
    A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.
    Hepatology. 2015 Apr 30. doi: 10.1002/hep.27877.
    PubMed     Text format     Abstract available


    March 2015
  93. TOSO C, Meeberg G, Hernandez-Alejandro R, Dufour JF, et al
    Total Tumor Volume and Alpha Fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
    Hepatology. 2015 Mar 17. doi: 10.1002/hep.27787.
    PubMed     Text format     Abstract available


    October 2014
  94. NAVARRO VJ, Barnhart H, Bonkovsky HL, Davern T, et al
    Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
    Hepatology. 2014;60:1399-408.
    PubMed     Text format     Abstract available


    September 2014
  95. HALAZUN KJ, Rana AA, Patzer RE, Samstein B, et al
    Re: - Waiting time and transplantation for hepatocellular cancer: A balancing between tempus fugit and carpe diem.
    Hepatology. 2014 Sep 11. doi: 10.1002/hep.27435.
    PubMed     Text format    


  96. LAI Q, Lerut J
    Waiting time and transplantation for hepatocellular cancer: A balancing between tempus fugit and carpe diem.
    Hepatology. 2014 Sep 11. doi: 10.1002/hep.27434.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: